Search clinical trials for: Trophos

Total 6 results

Hoffmann-La Roche
European Commission

Completed

Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS (MITOTARGET)

Amyotrophic Lateral Sclerosis

Belgium, France, Germany, Spain, United Kingdom
Hoffmann-La Roche

Completed

Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy (CIPN)

Chemotherapy-Induced Peripheral Neuropathy

France
Hoffmann-La Roche
Ergomed GmbH

Completed

Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy

Diabetic Neuropathy

Croatia, Germany, Latvia, Poland, Serbia
Hoffmann-La Roche

Completed

Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

France
Hoffmann-La Roche

Completed

Safety Extension Study of TRO19622 in ALS

Amyotrophic Lateral Sclerosis

Belgium, France, Germany, Spain, United Kingdom
Hoffmann-La Roche
Trophos SA

Completed

A Study of the Excretion Balance of Radiocarbon and the Pharmacokinetics and Metabolic Profile of TRO19622 (Olesoxime)

Healthy Volunteer

3

Subscribe